Inventor · disambiguated record
Raymond Huntley
Also filed as: HUNTLEY RAYMOND
7 granted patents·4 pending applications·39 citations·filing 2011–2021
80Inventor score
Top patents by PatentIndex Score
11 records- 0193US10280184B2Heterocyclic kinase inhibitorsABBVIE INC·Filed 2015·Granted May 7, 2019·21 cites·12 claims
- 0287US9120749B2Quinoline derivatives and MELK inhibitors containing the sameMATSUO YO·Filed 2011·Granted Sep 1, 2015·14 cites·17 claims
- 0372US9067937B21,5-naphthyridine derivatives and MELK inhibitors containing the sameONCOTHERAPY SCIENCE INC·Filed 2012·Granted Jun 30, 2015·2 cites·15 claims
- 0469US2021179556A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 0568US8962648B2Tricyclic compounds and PBK inhibitors containing the sameNAKAMURA YUSUKE·Filed 2011·Granted Feb 24, 2015·1 cites·14 claims
- 0666US9345709B21,5-naphthyridine derivatives and MELK inhibitors containing the sameONCOTHERAPY SCIENCE INC·Filed 2015·Granted May 24, 2016·1 cites·12 claims
- 0766US2019284135A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 0865US9567339B2Primary carboxamides as BTK inhibitorsABBVIE INC·Filed 2014·Granted Feb 14, 2017·0 cites·20 claims
- 0958US9453025B2Tricyclic compounds and PBK inhibitors containing the sameONCOTHERAPY SCIENCE INC·Filed 2014·Granted Sep 27, 2016·0 cites·12 claims
- 1058US2017174624A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2017·Application pending·0 cites
- 1150US2019135836A1Heterocyclic kinase inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →